Related Experiment Video
Updated: Jul 3, 2026
08:01
Intracerebroventricular Injection of Amyloid-β Peptides in Normal Mice to Acutely Induce Alzheimer-like Cognitive Deficits
Published on: March 16, 2016
Apolipoprotein E4 domain interaction: synaptic and cognitive deficits in mice.
Ning Zhong1, Kimberly Scearce-Levie, Gayathri Ramaswamy
1Gladstone Institute of Neurological Disease, The J. David Gladstone Institutes, San Francisco, CA, USA.
Summary
Apolipoprotein E4 (apoE4) domain interaction alone causes synaptic deficits and memory issues in mice, suggesting it
Area of Science:
- Neuroscience
- Genetics
- Biochemistry
Background:
- Apolipoprotein E4 (apoE4) is a major genetic risk factor for Alzheimer's disease (AD).
- Key apoE4 properties include domain interaction, reduced stability, and lack of cysteine.
- Understanding apoE4's specific contributions to AD pathogenesis is crucial for therapeutic development.
Purpose of the Study:
- To investigate the role of apoE4's domain interaction in neurodegenerative disease.
- To assess if domain interaction alone is sufficient to cause synaptic pathology.
Main Methods:
- Utilized Arg-61 apoE mice, a model specifically engineered to display apoE4's domain interaction.
- Analyzed synaptic protein levels (synaptophysin, neuroligin-1) in the neocortex and hippocampus.
- Measured Arc expression following neuronal activation and assessed glutamate transporter 1 levels.
Main Results:
- Arg-61 mice showed age-dependent loss of synaptic proteins and reduced neuroligin-1.
- These mice exhibited impaired Arc expression and mild memory deficits in water-maze tests.
- Reduced glutamate transporter 1 levels indicated potential astrocyte dysfunction and excitotoxicity.
Conclusions:
- ApoE4's domain interaction, independent of other structural features, can induce synaptic pathology.
- Astrocyte dysfunction and impaired neuronal maintenance may contribute to apoE4-associated deficits.
- Targeting apoE4 domain interaction could be a therapeutic strategy for neurodegenerative diseases.
Related Concept Videos
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...